Month: March 2022

Virtual, Orchestrated Environment Supports Deployment of Point-to-Point Services through Standards-based Integration Across Satellite Ground Systems and Global Communications Networks SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that its OpenSpace™ Platform now supports integrated delivery of E-Line services using Carrier Ethernet-over-Satellite. Kratos’ OpenSpace Platform is the first and only completely virtual satellite ground system based upon an open, standards-based Software-Defined Networking (SDN) architecture that enables satellite operators and global communications networks to interoperate seamlessly. Introduced last year with support for Earth Observation and Remote Sensing missions, the OpenSpace...

ERAS-007, a potential best-in-class ERK1/2 inhibitor, is being evaluated clinically in combination with encorafenib and cetuximab in patients with BRAF V600E-mutant mCRC Erasca previously signed a clinical trial collaboration and supply agreement with Pfizer for encorafenib for use in the same study Preclinical data support the potential of ERAS-007 to block MAPK pathway reactivation and limit resistance to encorafenib and cetuximab treatment SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it has entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company for Lilly’s anti-EGFR antibody...

SOUTH SAN FRANCISCO, Calif., March 10, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today announced that management will present at the 32nd Annual Oppenheimer Healthcare Conference on Thursday, March 17, 2022 at 10:40 a.m. ET. To access the live or archived recording of the company presentation, please visit the investor section of the Tempest website at https://ir.tempesttx.com. About Tempest Therapeutics Tempest Therapeutics is a clinical-stage oncology company advancing small molecules that combine both tumor-targeted and immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s two novel clinical programs are TPST-1120 and TPST-1495, antagonists...

Presentation on Thursday, March 24th, 2022 at 3:30 PM ET NEW BRUNSWICK, N.J., March 10, 2022 (GLOBE NEWSWIRE) — DatChat, Inc. (“DatChat” or the “Company”) (Nasdaq: DATS), a communications and social media company that gives users the ability to communicate, share, and post with privacy and screen capture protection, announced today that it will be presenting virtually at the upcoming Ladenburg Thalmann Virtual Special Crypto Expo on Thursday, March 24th, at 3:30 PM ET. Darin Myman, Chief Executive Officer, will be giving the presentation. Event: DatChat Presentation at the Ladenburg Thalmann Virtual Special Crypto ExpoDate: Thursday, March 24th, 2022Time: 3:30 PM ET Register to watch the presentation here: conference.ladenburg.com. Investors can also request 1×1 meetings with Company on the event website. Summary...

iCAD’s award winning portfolio of breast health solutions to be featured at inaugural Pink Paradigm Summit, uniting clinical and advocacy leadership NASHUA, N.H., March 10, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will be showcasing its portfolio of innovative breast health solutions at the National Consortium of Breast Centers (NCoBC) Annual Conference in Las Vegas, NV from March 11-16 in the iCAD booth (#203). iCAD’s breast health solutions, including ProFound AI® for Digital Breast Tomosynthesis (DBT), or 3D mammography, will also be featured at the first-ever The New Pink Paradigm™ Summit, taking place on Sunday, March 13. At the event, clinical leadership and advocacy organizations will join forces to...

Newport Beach, CALIFORNIA, March 10, 2022 (GLOBE NEWSWIRE) — Agtech Global International, Inc. (Agtech) (OTC Pink: AGGL) announces that due to unexpected delays in Agtech’s funding of the purchase, the final consummation of the Memorandum of Understanding between Dr. Malcolm A. Leissring and the planned acquisition of his company NooMeds, LLC. will not proceed and is hereby terminated. As a result of this change, Dr. Leissring will not continue in the consulting role as Chief Scientific Officer and Agtech will not have any future involvement with the AD Foundation. Agtech is publicly traded on the OTC Markets (OTC Pink: AGGL). Headquartered in Newport Beach, California, Agtech is entering the rapidly developing markets for premium CBD consumer products through its recent acquisition of Galexxy Corporation and its joint venture...

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that management will be presenting a corporate overview and be available for 1-on-1 meetings at the 32nd Annual Oppenheimer Healthcare Conference taking place virtually on March 15-17, 2022.32nd Annual Oppenheimer Healthcare Conference (virtual) Date: March 17th, 2022 Presentation Time: 12:40pm – 1:10pm ET Speaker: Eliot Forster, Chief Executive Officer Format: Company Presentation Webcast Registration Link. A replay will be available following the presentation for 90 daysAbout F-star Therapeutics, Inc. F-star Therapeutics, Inc. is a clinical-stage...

MIAMI, March 10, 2022 (GLOBE NEWSWIRE) — Global Crossing Airlines Group Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce that the Neo Exchange Inc. (“NEO Exchange”) has granted final approval of the Company’s listing application and that the shares of Common Stock and Class B Non-Voting Common Stock of GlobalX will commence trading on the NEO Exchange as of 9:30am ET on March 16, 2022. GlobalX’s existing trading symbols “JET” and “JET.B” will remain unchanged as a result of the listing. The Company’s shares will be delisted from the TSX Venture Exchange at the close of market on March 15, 2022. Ed Wegel, CEO of GlobalX stated, “Within 18 months we have taken GlobalX from a start-up to now operating six aircraft and the completion of a listing on a senior stock exchange. As we continue...

Piezo Motion partners with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the Southern U.S. LAKEWOOD RANCH, Fla., March 10, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Benson Engineering today announce a partnership. Piezo Motion is a developer and leading manufacturer of automation technology. Benson Engineering, founded in 1946, is a family-owned manufacture representative group with offices in Texas and Missouri. Benson Engineering works primarily with original equipment manufacturers (OEMs) in Texas, Louisiana, Oklahoma, Arkansas, Kansas, Missouri, Nebraska and Iowa. Piezo Motion’s multifaceted rotary and linear motors are built with technology that provides a stable, accurate motor that is designed specifically for OEMs...